Our study focuses on identifying molecular drivers of ECM remodeling and therefore did not focus on tumor volume markers such as S100B.34 Nonetheless, the combined biomarker of MMP9 and volume had excellent discriminatory ability, and incorporation of radiographic factors such as the presence of CSF cleft and brainstem compression further improved the performance of the panel. The gene discussed is S100B; the disease is neoplasm.